Heinz-Peter Schmitt

This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2007-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinz-Peter Schmitt. Retrieved from https://idiyas.com/inventor/heinz-peter-schmitt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 31(Granted Patents)

Location History:

Ingelheim, DE (2007 - 2011)
Ingelheim and Rhein, DE (2013)
Ingelheim am Rhein, DE (2015)

Company Filing History:

5 out of 1,561

Boehringer Ingelheim International Gmbh

patents

Years Active: 2007-2015

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9109005 - Method for manufacturing of ciclesonide (2015-08-18),

2. 8354543 - Process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof (2013-01-15),

3. 7880016 - Process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides (2011-02-01),

4. 7459566 - 1,2,4-oxadiazol-5-one-4-(benzimidazolylmethylamino)benzamidine compounds (2008-12-02),

5. 7202368 - Process for the preparation of 4-(benzimidazolymethylamino) benzamidines (2007-04-10),

Title: The Innovations of Heinz-Peter Schmitt

Introduction

Heinz-Peter Schmitt is a notable inventor based in Ingelheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of corticosteroids. With a total of 5 patents to his name, Schmitt's work has had a considerable impact on respiratory treatments.

Latest Patents

One of Schmitt's latest patents is a method for manufacturing ciclesonide. This invention relates to a process for preparing the corticosteroid ciclesonide, which is used for the treatment of respiratory complaints, in epimerically pure form. Another significant patent is for the process of preparing 4-(benzimidazolylmethylamino)-benzamides and the salts thereof. This invention focuses on a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine.

Career Highlights

Throughout his career, Schmitt has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His work in these organizations has allowed him to contribute to the advancement of medical treatments.

Collaborations

Heinz-Peter Schmitt has collaborated with several professionals in his field, including Georg Zerban and Arndt Hausherr. These collaborations have further enriched his research and development efforts.

Conclusion

Heinz-Peter Schmitt's innovative work in the pharmaceutical industry has led to significant advancements in respiratory treatments. His contributions continue to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.